3 Recruiting Platinum-resistant Ovarian Cancer Phase 3 Clinical Trials
Active phase 3 studies for platinum-resistant ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Platinum-resistant Ovarian Cancer studiesPhase 3 Studies for Platinum-resistant Ovarian Cancer
🔵 Active, Not Recruiting Phase2 / Phase3
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
📍 HonorHealth Cancer Care — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
📍 Alaska Women's Cancer Care — Anchorage, Alaska
View Study & Checklist ➔ 🟢 Recruiting Phase3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
📍 The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔